Evidence map›Paper›PMID 22895365›Full record

ArticleThe Journal of investigative dermatology2012

Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes.

Masakazu Kawaguchi, Julio C Valencia, Takeshi Namiki, Tamio Suzuki, Vincent J Hearing

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Cells · 2021
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Masakazu KawaguchiLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Julio C Valencia
Takeshi Namiki
Tamio Suzuki
Vincent J Hearing
National Institutes of Health · USYamagata University · JP

Funding

Characterization of Pigmentary Disorders and Melanoma TargetingZIABC010785 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2009 to 2014
$3.0M
The Regulation of Mammalian PigmentationZIABC010786 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2009 to 2014
$2.2M
Intramural NIH HHS ZIA BC010786
6 · The paper itself

Abstract

Diacylglycerol (DAG) increases the melanin content of human melanocytes in vitro and increases the pigmentation of guinea pig skin in vivo, but the mechanism(s) underlying those effects remain unknown. In this study, we characterized the role of diacylglycerol kinase (DGK), which phosphorylates DAG to generate phosphatidic acid, in the regulation of pigmentation. Ten isoforms of DGK have been identified, and we show that DGKζ is the most abundant isoform expressed by human melanocytic cells. Melanin content, tyrosinase activity, and tyrosinase protein levels were significantly reduced by a DGK inhibitor, but tyrosinase and microphthalmia-associated transcription factor messenger RNA (mRNA) levels were not changed by that inhibition, and there were no effects on the expression of other melanogenesis-related proteins. Isoform-specific small interfering RNAs showed that knockdown of DGKζ decreased melanin content and tyrosinase expression in melanocytic cells. Overexpression of DGKζ increased tyrosinase protein levels, but did not increase tyrosinase mRNA levels. Glycosidase digestion revealed that inhibition of DGK reduced only the mature form of tyrosinase, and the decrease of tyrosinase resulting from DGK inhibition could be blocked partially by protease inhibitors. These results suggest that DGK regulates melanogenesis via modulation of the posttranslational processing of tyrosinase, which may be related with the protein degradation machinery.

Indexed as

Adenoviridaealpha-MSHAnimalsCell Line, TumorDiacylglycerol KinaseEndoplasmic ReticulumEnzyme InhibitorsEpidermal CellsFlavonoidsGene Expression Regulation, EnzymologicHormonesHumansIndolesMaleimidesMelaninsMelanocytes2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-onealpha-MSHDGKZ protein, humanDiacylglycerol KinaseEnzyme InhibitorsFlavonoidsHormonesIndolesMaleimidesMelaninsMembrane GlycoproteinsMonophenol MonooxygenaseOxidoreductasesPiperidinesProtein Kinase InhibitorsQuinazolinonesR 59949TYRP1 protein, human

Identifiers

PMID22895365
PMCPMC3502659
OpenAlexW2092655353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.